30 results on '"Van Der Ende, Marchina"'
Search Results
2. Imiquimod 5% cream for five consecutive days a week in an HIV-infected observational cohort up to 32 weeks in the treatment of high-grade squamous intraepithelial lesions
3. How does weight influence tenofovir disoproxil-fumarate induced renal function decline?
4. Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women
5. Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy: two cases
6. Photodynamic therapy with systemic meta-tetrahydroxyphenylchlorin in the treatment of anal intraepithelial neoplasia, grade 3
7. HIV-associated Idiopathic Noncirrhotic Portal Hypertension: Risk factors And Association With Didanosine: 1179
8. Current and future applications of dried blood spots in viral disease management
9. Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir
10. Early versus Deferred Antiretroviral Therapy for HIV
11. Long-term survival after kidney transplantation in an HIV-positive patient
12. Complete clinical and virological remission of refractory HIV-related Kaposiʼs sarcoma with pegylated interferon alpha
13. Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism
14. Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modifications
15. Nelfinavir and nevirapine side effects during pregnancy
16. Sexually transmitted reinfection with a new hepatitis C genotype during pegylated interferon and ribavirin therapy
17. Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort study
18. Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients
19. Low Nevirapine Plasma Concentrations Predict Virological Failure in an Unselected HIV-1-Infected Population
20. Post-exposure prophylaxis
21. Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study
22. Once-daily indinavir plus ritonavir: preliminary results of the PIPO study
23. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine
24. Antiretroviral Therapy in Patients with Dual Infection with Human Immunodeficiency Virus Types 1 and 2
25. The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine
26. A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience
27. Substituting nevirapine for protease inhibitors because of intolerance
28. CD4 T cells remain the major source of HIV-1 during end stage disease
29. Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients
30. HIV-2 infection in 12 European residents: virus characteristics and disease progression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.